NovaBridge Biosciences (FRA:0VY)

Germany · Delayed Price · Currency is EUR

2.080

-0.080 (-3.70%)

Last updated: Apr 24, 2026, 8:04 AM CET

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Oncology			632.00K	-1.55M	13.86M	236.29M	4.31M
Oncology Growth			-	-	-94.14%	5384.30%	-44.90%
Total			632.00K	-1.55M	13.86M	236.29M	4.31M
Total Growth			-	-	-94.14%	5384.30%	-44.90%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
United States			632.00K	-1.55M	-	-	-
People's Republic of China			-	-	13.86M	236.29M	4.31M
People's Republic of China Growth			-	-	-94.14%	5384.30%	-44.90%
Total			632.00K	-1.55M	13.86M	236.29M	4.31M
Total Growth			-	-	-94.14%	5384.30%	-44.90%

Source: S&P Global Market Intelligence.